Prestige Consumer Healthcare
PBH
#4766
Rank
HK$16.78 B
Marketcap
HK$354.18
Share price
2.22%
Change (1 day)
-24.77%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2023 (TTM): -HK$12.87

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is HK$25.57. In 2022 the company made an earnings per share (EPS) of HK$32.95 an increase over its 2021 EPS that were of HK$29.50.

EPS history for Prestige Consumer Healthcare from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$12.87-139.06%
2022HK$32.9511.7%
2021HK$29.5013.6%
2020HK$25.97-651.67%
2019-HK$4.71-148.78%
2018HK$9.65-83.29%
2017HK$57.73437.23%
2016HK$10.75-34.13%
2015HK$16.3252.94%
2014HK$10.67-8.11%
2013HK$11.6162.64%
2012HK$7.144.6%
2011HK$6.8270.59%
2010HK$4.00-113.97%
2009-HK$28.63-621.43%
2008HK$5.497.69%
2007HK$5.101.56%
2006HK$5.02-681.82%
2005-HK$0.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.40 104.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
HK$53.03 107.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.18 61.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.57-78.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$21.21-17.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
HK$38.20 49.39%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
HK$25.10-1.84%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$22.57-11.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
-HK$232.35-1,008.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
HK$9.57-62.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel